M. Takahashi: "Yes, that's an estimate assuming everything goes smoothly."
"Moreover, even if our energy density reaches 700kWh/kg, our charge and discharge efficiency will still be difficult to match that of lithium batteries using innovative biotechnology."
He Xiongzhongxin asked, "Is it possible to bypass their technology patents?"
M. Takahashi: "It's unrealistic. First of all, even if we design a similar metal structure based on the lithium metal structure of Kechuang Bio, the energy density will be almost the same as that of Kechuang Bio's lithium battery."
"But we don't know the industrial process, so it's meaningless to only have laboratory methods."
He Xiongzhongxin: "What if we could obtain the industrial manufacturing method for the cathode material of Kechuang Biotechnology?"
M. Takahashi: "I cannot guarantee that we will be able to circumvent their patent barriers."
"So far, no pharmaceutical company has been able to bypass the technological barriers of Kechuang Bio's industrial method for producing endorphins."
"Kechuang Bio takes 30% of the global profits from endorphins every year."
The patent licensing fees for endorphins are very high.
Currently, endorphins hold over 50% of the global analgesic market share, with annual sales of approximately 100 billion US dollars. Kechuang Bio's profits from this segment exceed 10 billion US dollars.
The explosive growth in this revenue mainly occurred in 2022.
He Xiongzhongxin: "We are conducting research and development as well as intelligence gathering, simultaneously."
......
"LG has been deeply rooted in the Chinese market for many years and has always regarded China as the most important market for our future development."
"We hope to establish a deep cooperative relationship with Kechuang Bio in the field of lithium batteries. As a giant in China, Kechuang Bio and I can achieve perfect complementarity in resource integration."
After exchanging a few pleasantries, Ko Myung-hwan, President of LG Chem Greater China, got straight to the point.
Cheng Gang knew he couldn't make the decision himself; it was Zheng Li's decision, and the authorization was only granted to domestic Chinese companies.
However, it was impossible to say it directly in public, so Cheng Gang said tactfully, "Kechuang Bio is still a newcomer in the field of lithium batteries."
"As the world's leading lithium battery company, there are many things we need to learn from LG Chem. Their technological strength is beyond doubt."
"Science and Technology Innovation Biotechnology's technology still has many immature aspects, and we hope to have the opportunity to cooperate with LG Chem in the future."
Gao Minghuan understood what the other party meant, and he asked, "Mr. Cheng, there is a Chinese proverb that says: 'Speak frankly and openly.'"
"What I'm about to say might be a bit direct, please forgive me."
"LG Chem has already collaborated with Scitech Biotech on endorphins. LG Chem's endorphin production ranks second in Korea, second only to Samsung."
“After the partnership was established, LG Chem pays Sci-Tech Biotech hundreds of millions of US dollars in patent licensing fees every year, and this fee has never been in arrears.”
"We have a history of cooperation, so why is Kechuang Bio unwilling to cooperate with LG Chem this time?"
"Is it because we want to support the domestic industrial chain? But China's domestic lithium battery industrial chain is not weak, and it is even arguably the world's number one. It does not need support at all."
"Logically speaking, shouldn't your country's biopharmaceutical industry be supported even more?"
"I'm curious, what are your company's strategic considerations?"
"As a global giant, why does it show a certain territorial protection tendency in this patent?"
Gao Minghuan's question was sharp, and Cheng Gang wanted to retort: What does this have to do with you?
Unfortunately, all they could say was politely, "This is due to certain considerations. We will consider opening up the technology to foreign companies in the future."
"However, due to current production limitations, it is not possible to open up to battery manufacturers worldwide."
"Since you are so frank, I can also reveal a little bit."
"Since you've come here today to discuss Kechuang Biotechnology's lithium battery technology, I presume your company has already obtained samples and conducted tests?"
Gao Minghuan: "Yes."
Cheng Gang continued, "You should know that our lithium battery cathode technology adds a unique graphene coating between the lithium metal cathode and the electrolyte."
"Unlike common graphene coatings, Kechuang Bio's graphene coating requires specialized equipment to print on the lithium metal cathode material."
"Similar to lithography machines, the production capacity of this equipment is limited and cannot meet the needs of all manufacturers."
Cheng Gang is telling the truth. Because it is a three-dimensional graphene structure, it is not like the current mainstream method of simply coating a layer of graphene on top.
Specialized graphene coating equipment is required. The underlying logic of this technology is somewhat similar to that of a photolithography machine, both of which use graphene to print fine patterns onto lithium metal cathode materials.
It can be said to be the lithography machine of the lithium battery field.
To some extent, this is also a countermeasure. Kechuang Bio deliberately split it up.
Continue read on readnovelmtl.com
